Back to search

University of Thessaly (UTH)

Το οξειδωτικό stress και ο αγγειακός ενδοθηλιακός αυξητικός παράγοντας στους ασθενείς με πρωτοπαθή καρκίνο πνεύμονα

Abstract

dc:description

OBJECTIVE: The aim of the present study was to determine Vascular endothelial growth factor (VEGF) and Oxidative stress (OS) levels, to investigate if there is any association between them and with other clinipathological factors and to assess the relevance of these levels to disease outcome. Materials and Methods: We measured serum OS and VEGF levels in 81 patients (age 62.48 ± 0.94 SEM) with primary lung cancer before any treatment (51 NSCLC; 9 patients stage I, 3 stage II, 16 stage III and 23 stage IV and 30 SCLC; 1 patients stage I, 2 stage II, 10 stage III and 17 stage IV) and in 25 normal subjects. The histological type of NSCLC was: 12/adenocarcinoma, 27/squamous cell carcinoma and 12 with no differentiated NSCLC. We also measured OS and VEGF levels after cisplatin based treatment in 43 of those 81 patients. The serum VEGF levels were measured with enzyme linked immunosorbent assay (ELIZA) and OS levels were detected by a commercially available assay (D-ROMs test, Diacron, Grossetto, Italy). Results: The serum levels of VEGF and OS were higher than those in normal subjects (p=0.0095 and p<0.0001, respectively). VEGF presented a significant correlation with OS levels before (p=0.0013, r=0.35) and after chemotherapy (p=0.025, r=0.34). There was no relevance of pretreatment serum VEGF and OS levels in response to therapy. Although, in the responders, after chemotherapy there was a significant decrement in serum VEGF leves (p=0.047) and a greater OS variation (p=0.03). Also, it was found a signifigant association between VEGF and OS levels and age of Lung cancer patients (p=0.004 and p=0.02, respectively). Nevertheless, there was no relevance with the others clinopathological factors. Patients with an OS serum level higher than the median serum level (552 UCarr) had a significantly shorter overall survival than those with a lower serum level (p=0.015, Log Rank Test). Also, shorter overall survival had patients with VEGF serum levels higher than the median (418pg/ml) serum level (p=0.048, Log Rank Test). Independent prognostic factors were found only VEGF and age of Lung cancer patients (p=0.0291and p=0.0423, respectively). Conclusions: High pre-treatment OS and VEGF levels may predict worse survival. Additionally, the correlation between these markers might implicate new aspects of lung cancer therapy and in conjunction with other clinical data, might be used for monitoring the patients with lung cancer.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Κατσαμπέκη-Κατσαφλή, Αλεξάνδρα
  • Katsabeki-Katsafli, Alexandra

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/18189

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Κατσαμπέκη-Κατσαφλή, Αλεξάνδρα; Katsabeki-Katsafli, Alexandra. Το οξειδωτικό stress και ο αγγειακός ενδοθηλιακός αυξητικός παράγοντας στους ασθενείς με πρωτοπαθή καρκίνο πνεύμονα. University of Thessaly (UTH), 2009. http://hdl.handle.net/10442/hedi/18189